Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
John McAdory
Observed names:
J. Mcadory,
John Mcadory
OpenAlex ID:
A5079950375
CORE1: Phase 2, single-arm study of CG0070 combined with pembrolizumab in patients with nonmuscle-invasive bladder cancer (NMIBC) unresponsive to bacillus Calmette-Guerin (BCG).
2022
·
Roger Li
, Gary D. Steinberg
, et al.
·
Journal of Clinical Oncology
·
32
955 CORE1: phase 2, single arm study of CG0070 combined with pembrolizumab in patients with non muscle invasive bladder cancer (NMIBC) unresponsive to bacillus calmette-guerin (BCG)
2021
·
Roger Li
, Gary Steinberg
, et al.
·
8
PDF
Pd13-08 Core1: Phase 2 Single Arm Study of Cg0070 Combined With Pembrolizumab in Patients With Non Muscle Invasive Bladder Cancer Unresponsive to Bacillus Calmette-guerin (bcg)
2023
·
Roger Li
, Gary Steinberg
, et al.
·
The Journal of Urology
·
2
666 Phase 2, single arm study of CG0070 combined with pembrolizumab in patients with non-muscle invasive bladder cancer (NMIBC) unresponsive to bacillus calmette-guerin (BCG)
2022
·
Roger Li
, Gary Steinberg
, et al.
·
Regular and Young Investigator Award Abstracts
·
2
PDF
426 A phase 3, single-arm study of CG0070 in subjects with non-muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG)
2021
·
Ed Uchio
, Donald Lamm
, et al.
·
Regular and Young Investigator Award Abstracts
·
2
PDF
CORE1: Phase 2 single arm study of CG0070 combined with pembrolizumab in patients with non-muscle invasive bladder cancer unresponsive to Bacillus Calmette-Guerin (BCG)
2023
·
R. Li
, G.S. Steinberg
, et al.
·
European Urology
·
1
Abstract CT036: CORE1: Phase 2, single arm study of CG0070 combined with pembrolizumab in patients with non-muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG)
2022
·
Roger Li
, Gary Steinberg
, et al.
·
Cancer Research
·
1
Show more works
View as search
Works count:
7
Citation count:
48
H-index:
2
I10-index:
1
Year
Topic
Type
